Treatment deintensification in human papillomavirus ‐positive oropharynx cancer: Outcomes from the National Cancer Data Base
CONCLUSIONSDeintensification of treatment from chemoradiotherapy to radiotherapy or surgery alone in cases of HPV+ AJCC eighth edition stage I or stage II disease may compromise patient safety. Treatment intensification to triple‐modality therapy for patients with stage III disease may improve survival in this group. Cancer 2017. © 2017 American Cancer Society.
Source: Cancer - Category: Cancer & Oncology Authors: Shayan Cheraghlou, Phoebe K. Yu, Michael D. Otremba, Henry S. Park, Aarti Bhatia, Cheryl K. Zogg, Saral Mehra, Wendell G. Yarbrough, Benjamin L. Judson Tags: Original Article Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Epidemics | Epidemiology | Genital Warts | Human Papillomavirus (HPV) | Oropharyngeal Cancer | Study